These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Khan NF; Mant D; Carpenter L; Forman D; Rose PW Br J Cancer; 2011 Nov; 105 Suppl 1(Suppl 1):S29-37. PubMed ID: 22048030 [TBL] [Abstract][Full Text] [Related]
4. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer. Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462 [TBL] [Abstract][Full Text] [Related]
5. Cancer screening and preventative care among long-term cancer survivors in the United Kingdom. Khan NF; Carpenter L; Watson E; Rose PW Br J Cancer; 2010 Mar; 102(7):1085-90. PubMed ID: 20234361 [TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study. Yang K; Doege D; Thong MSY; Koch-Gallenkamp L; Weisser L; Bertram H; Eberle A; Holleczek B; Nennecke A; Waldmann A; Zeissig SR; Pritzkuleit R; Jansen L; Brenner H; Arndt V Cancer; 2024 Apr; 130(7):1158-1170. PubMed ID: 37996981 [TBL] [Abstract][Full Text] [Related]
7. Quality of care for chronic diseases in a British cohort of long-term cancer survivors. Khan NF; Mant D; Rose PW Ann Fam Med; 2010; 8(5):418-24. PubMed ID: 20843883 [TBL] [Abstract][Full Text] [Related]
8. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study. Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977 [No Abstract] [Full Text] [Related]
9. CO-EXISTING PROSTATE CANCER AND DIABETES MELLITUS: IMPLICATIONS FOR PATIENT OUTCOMES AND CARE. Karlin NJ; Amin SB; Verona PM; Kosiorek HE; Cook CB Endocr Pract; 2017 Jul; 23(7):816-821. PubMed ID: 28534688 [TBL] [Abstract][Full Text] [Related]
10. Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. Snyder CF; Frick KD; Herbert RJ; Blackford AL; Neville BA; Wolff AC; Carducci MA; Earle CC J Clin Oncol; 2013 Mar; 31(9):1140-8. PubMed ID: 23401438 [TBL] [Abstract][Full Text] [Related]
11. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK. Kowall B; Stang A; Rathmann W; Kostev K Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313 [TBL] [Abstract][Full Text] [Related]
12. Does delay in planned diabetes care influence outcomes for aboriginal Australians? A study of quality in health care. Li SQ; Guthridge S; Lawton P; Burgess P BMC Health Serv Res; 2019 Aug; 19(1):582. PubMed ID: 31426768 [TBL] [Abstract][Full Text] [Related]
13. Diabetes care and complications in primary care in the Tshwane district of South Africa. Webb EM; Rheeder P; Van Zyl DG Prim Care Diabetes; 2015 Apr; 9(2):147-54. PubMed ID: 24933340 [TBL] [Abstract][Full Text] [Related]
14. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts. Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426 [TBL] [Abstract][Full Text] [Related]
15. Relationship Between Quality of Comorbid Condition Care and Costs for Cancer Survivors. Frick KD; Snyder CF; Herbert RJ; Blackford AL; Neville BA; Wolff AC; Carducci MA; Earle CC J Oncol Pract; 2016 Jun; 12(6):e734-45. PubMed ID: 27165487 [TBL] [Abstract][Full Text] [Related]
16. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Khaw KT; Wareham N; Bingham S; Luben R; Welch A; Day N Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):915-9. PubMed ID: 15184246 [TBL] [Abstract][Full Text] [Related]
17. BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database. Lemanska A; Price CA; Jeffreys N; Byford R; Dambha-Miller H; Fan X; Hinton W; Otter S; Rice R; Stunt A; Whyte MB; Faithfull S; de Lusignan S PLoS One; 2022; 17(10):e0275369. PubMed ID: 36197912 [TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act. Virani SS; Akeroyd JM; Ramsey DJ; Chan WJ; Frazier L; Nasir K; S Rajan S; Ballantyne CM; Petersen LA Am Heart J; 2016 Nov; 181():74-82. PubMed ID: 27823696 [TBL] [Abstract][Full Text] [Related]
19. Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium. Amadou A; Freisling H; Jenab M; Tsilidis KK; Trichopoulou A; Boffetta P; Van Guelpen B; Mokoroa O; Wilsgaard T; Kee F; Schöttker B; Ordóñez-Mena JM; Männistö S; Söderberg S; Vermeulen RCH; Quirós JR; Liao LM; Sinha R; Kuulasmaa K; Brenner H; Romieu I Br J Cancer; 2021 May; 124(11):1882-1890. PubMed ID: 33772152 [TBL] [Abstract][Full Text] [Related]
20. Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data. Gordon-Dseagu VL; Mindell JS; Steptoe A; Moody A; Wardle J; Demakakos P; Shelton NJ PLoS One; 2015; 10(3):e0119882. PubMed ID: 25785731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]